Link to this page
Myocardial Infarction Ontology
Last uploaded:
December 18, 2024
Jump to:
| Id | http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02641
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02641
|
|---|---|
| Preferred Name | P2Y12 inhibitor |
| Definitions |
P2Y12 receptors are present on blood platelets. These receptors are responsible for platelet aggregation and clotting. Clopidogrel, prasugrel, ticagrelor, ticlopidine, and cangrelor are P2Y12 receptor inhibitors and can be used as antiplatelets. Cangrelor is a newer agent which is administered via the intravenous route. [url:https://pubmed.ncbi.nlm.nih.gov/30178075/]
|
| Synonyms |
ADP receptor subtype P2Y12 antagonist
P2Y12 inhibitors
ADP receptor subtype P2Y12 antagonists
purinergic receptor subtype P2Y12 antagonist
purinergic receptor subtype P2Y12 antagonists
P2Y12 receptor antagonist
P2Y12 antagonist
P2Y12 antagonists
P2Y12 receptor antagonists
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | P2Y12 receptors are present on blood platelets. These receptors are responsible for platelet aggregation and clotting. Clopidogrel, prasugrel, ticagrelor, ticlopidine, and cangrelor are P2Y12 receptor inhibitors and can be used as antiplatelets. Cangrelor is a newer agent which is administered via the intravenous route. [url:https://pubmed.ncbi.nlm.nih.gov/30178075/] |
|---|---|
| label | P2Y12 inhibitor
|
| prefLabel | P2Y12 inhibitor
|
| reference |
PMID:30178075
CHEBI:68563
|
| synonyms |
ADP receptor subtype P2Y12 antagonist
P2Y12 inhibitors
ADP receptor subtype P2Y12 antagonists
purinergic receptor subtype P2Y12 antagonist
purinergic receptor subtype P2Y12 antagonists
P2Y12 receptor antagonist
P2Y12 antagonist
P2Y12 antagonists
P2Y12 receptor antagonists
See more
See less
|
| subClassOf | |
| type | |
| MIO_ID | MIO:02641
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |